The short answer: In a 2024 clinical trial combining whole-body hyperthermia with CBT, 91.7% of completers no longer met diagnostic criteria for major depressive disorder. A single session produced anti-depressant effects lasting up to 6 weeks, driven by a serotonergic signalling cascade that SSRIs target through a parallel mechanism.
Andrew Huberman has described sauna's neurological mechanisms as among the most underappreciated in the longevity and mental health literature.
In 2024, Ashley Mason's team at UCSF published trial data showing that whole-body hyperthermia, the deliberate elevation of core body temperature through heat exposure, produced a 91.7% remission rate in completers when combined with cognitive behavioural therapy. The number is striking enough to require immediate context: this was an early-stage trial, not a large-scale RCT. But the biological mechanism behind it is not speculative, and the effects were not brief.
What the Clinical Data Shows
The Mason et al. 2024 trial (PMC12553885) enrolled participants with diagnosed major depressive disorder and delivered a protocol combining whole-body hyperthermia sessions with CBT. Among completers, 91.7% no longer met diagnostic criteria for MDD at follow-up. Beck Depression Inventory-II scores dropped by an average of 15.83 points across the cohort, a clinically significant change. Anti-depressant effects from a single WBH session lasted up to 6 weeks in measured participants.
The duration of effect is the detail that distinguishes this from superficial mood elevation. A 6-week window from a single session indicates a neurobiological change rather than a temporary sympathetic arousal response. Something downstream of the heat exposure is shifting in a sustained way.
A 15.83-point drop on the BDI-II is not a rounding error. It is the scale of change associated with effective pharmaceutical treatment, produced by heat.
The Serotonin Connection
Ashley Mason's mechanistic hypothesis centres on peripheral thermoreceptors: specialised sensory neurons in the skin and subcutaneous tissue that detect heat. When these thermoreceptors are warmed sufficiently, they send ascending signals through the spinal cord to the dorsal raphe nucleus, the primary serotonin-producing region of the brain. The dorsal raphe responds by increasing serotonergic output to the forebrain, including the prefrontal cortex and limbic structures central to mood regulation.
This pathway maps directly onto a known SSRIs mechanism. Selective serotonin reuptake inhibitors enhance serotonergic transmission by blocking re-uptake at the synapse; heat exposure appears to increase transmission by stimulating the production end of the same system. Both interventions converge on enhanced peripheral blood flow as a downstream signature, which Mason's group has identified as a shared physiological marker of response. Patients with major depressive disorder show blunted peripheral vasodilation as a trait characteristic; both SSRIs and whole-body hyperthermia appear to correct this. The Patrick and Johnson 2021 review in Experimental Gerontology (PMID 34363927) situates the thermoreceptor pathway within a broader synthesis of sauna's neurobiological effects.
The practical implication: warming the body peripherally, not just centrally, appears to be the trigger. Standard sauna activates the same thermoreceptor pathway. Infrared sauna may do so more efficiently because infrared radiation penetrates the skin to warm subcutaneous tissue directly, rather than heating through convection alone.
The dorsal raphe nucleus is not a discovery. SSRIs have targeted its downstream output for decades. Sauna appears to stimulate the same network from a different entry point.
The Dynorphin Mechanism: Why You Have to Stay In
Between 12 and 15 minutes into a sauna session, something shifts. Sustained heat stress triggers the release of dynorphin, an endogenous opioid that binds kappa-opioid receptors. Dynorphin produces dysphoria: a subjective sense of discomfort, mild unease, or the urge to exit. This is the mechanism behind the resistance people feel during longer sessions, and it is not incidental to the benefit. It is the mechanism of the benefit.
Dynorphin's binding of kappa-opioid receptors initiates a compensatory upregulation of mu-opioid receptors. Mu-opioid receptors are the target of beta-endorphin, the body's primary endogenous opioid associated with euphoria, reduced anxiety, and the post-exercise mood elevation commonly called runner's high. When mu-opioid receptors are upregulated by the prior dynorphin response, the beta-endorphin released on exiting the sauna binds to a more sensitive, more numerous receptor population. The result is a pronounced post-session mood elevation that outlasts the session itself.
Roland Griffiths at Johns Hopkins identified mu-opioid receptor sensitisation as a core feature of this response and noted its potential relevance to opioid addiction recovery: a non-pharmacological pathway to mu-opioid receptor stimulation, achieved through regulated heat stress. The clinical implications of this for addiction medicine remain under active investigation. For depression specifically, the sustained mu-opioid sensitisation produced by repeated sessions may account for the 6-week effect duration observed in the Mason trial.
Cutting sessions short before the dynorphin response matures blunts the entire rebound sequence. Sessions ending before the 12–15 minute threshold produce the sauna health benefits and norepinephrine effects of heat exposure without fully activating the kappa-to-mu receptor cascade. For mood outcomes specifically, session duration is not a convenience variable.
The Protocol: Standard Sauna vs Whole-Body Hyperthermia
The Mason 2024 trial used a specific whole-body hyperthermia protocol: an infrared sauna dome targeting a core temperature of 38.5°C, requiring approximately 82 minutes of heat exposure to reach that target, followed by a 30-minute monitored cool-down. This is a clinical protocol, administered with medical monitoring and combined with CBT sessions. It is not a home sauna routine.
The same thermoreceptor-to-dorsal-raphe pathway activates in a standard sauna, but with less precise temperature control and a faster ambient heat rise. Standard Finnish sauna at 80–100°C will activate the dynorphin cascade in a shorter elapsed time than an infrared dome session, because ambient temperature is higher. The core temperature target (38.5°C) remains the functional benchmark regardless of the heat source. Norepinephrine increases of up to 310% in men and 86% in women have been documented with standard sauna use, as synthesised in the Patrick and Johnson 2021 review. BDNF rises from 25.9 to 28.3 pg/L across 10 whole-body hyperthermia sessions.
Bryan Johnson, the longevity researcher and protocol designer, incorporated daily sauna into his Blueprint stack in 2024 and has attributed consistent mood stability and cognitive clarity improvements to the practice. This is a single-subject n=1 data point, not clinical evidence, but it reflects the protocol consistency the mechanism requires.
What the Research Cannot Yet Claim
The Mason 2024 trial is early-stage. A 91.7% remission rate in completers is a remarkable finding, but completers are not the full enrolled population; dropout rates in hyperthermia trials tend to be non-trivial, and the figures reported for completers require a full read of the trial design before being applied broadly. No large-scale Phase 3 RCT of whole-body hyperthermia for depression exists at the time of writing.
Sauna is not a replacement for clinical treatment (Peter Attia discusses this nuance) of major depressive disorder. Antidepressants, psychotherapy, and in severe cases ECT or TMS, have established efficacy profiles across thousands of patients and decades of trial data. The mechanistic overlap between sauna and SSRIs does not mean sauna replaces SSRIs; it means the same neurobiological targets can potentially be reached through multiple inputs. For someone already in clinical treatment, sauna may function as a complementary input rather than a substitution. That framing is not a hedge: it is the honest position given the current state of the evidence.
The Hannuksela and Ellahham 2001 review in the American Journal of Medicine (PMID 11165553) addressed the general safety and physiological effects of sauna, establishing the broad picture of autonomic and cardiovascular responses that later mechanistic work has built on. The Laukkanen 2018 Mayo Clinic Proceedings review (PMID 30077204) extended this to cover neurological outcomes. Neither paper claims therapeutic equivalence with clinical treatment for depression.
The evidence for sauna and depression is among the most mechanistically coherent in the broader sauna literature. That is not the same as clinical proof. Both things are true at once.
Frequently Asked Questions
Can sauna replace antidepressants?
No. Antidepressants have established efficacy across large randomised trials. The Mason 2024 trial is early-stage and used WBH combined with CBT, not sauna as a standalone replacement for medication. The shared serotonergic mechanism is scientifically interesting but does not establish therapeutic equivalence. Anyone currently on antidepressants should not alter their prescription based on sauna research. The appropriate framing is complementary input, not substitution.
How long does a session need to be to produce mood effects?
The dynorphin cascade, which drives the mu-opioid receptor sensitisation underlying the post-session mood elevation, requires the session to pass the 12–15 minute threshold at temperature. Sessions ending before this point activate thermoreceptor pathways and produce norepinephrine increases but do not complete the kappa-to-mu receptor sequence. For mood-specific outcomes, 20 minutes at temperature is the practical minimum. The Mason 2024 clinical protocol used approximately 82 minutes to reach the 38.5°C core temperature target.
Does the dysphoria during a session mean it is not working?
The dysphoria is the mechanism working. Dynorphin-induced discomfort between minutes 12 and 15 is the kappa-opioid receptor stimulus that triggers subsequent mu-opioid upregulation. Exiting the sauna when the dysphoria peaks stops the cascade before the beneficial half of the response occurs. The discomfort is a signal that the relevant biological threshold has been crossed, not a reason to terminate the session.
Does the effect work the same way for women as men?
Women show a different norepinephrine response to sauna: approximately 86% increase versus 310% in men, reflecting different thermoregulatory physiology. The serotonergic and dynorphin pathways are not sex-differentiated in the same way. The Mason 2024 trial enrolled participants across sexes and reported combined outcomes. Whether the 6-week anti-depressant effect duration differs by sex has not been specifically characterised in the published data.
Does a cold plunge after sauna reduce the mood benefits?
Immediate cold plunge after a sauna session triggers a rapid sympathetic response that may interrupt the beta-endorphin binding phase of the post-session mood response. The Mason clinical protocol used a 30-minute gradual cool-down, not cold immersion. For cardiovascular and recovery protocols, cold contrast therapy has separate evidence. For mood-specific sauna outcomes, allowing the cool-down to proceed at room temperature is the protocol the mechanism supports.
Is infrared sauna more effective than traditional sauna for depression?
The Mason 2024 trial used an infrared dome, which allows more precise core temperature monitoring. Traditional Finnish sauna activates the same thermoreceptor-to-dorsal-raphe pathway but does so through higher ambient heat rather than direct infrared tissue penetration. At equivalent core temperatures, the downstream mechanisms are likely comparable. Infrared sauna's advantage in clinical research is measurability, not necessarily superior biological effect. For home use, consistent session duration and temperature are more important than the heat modality.
Can sauna be used during an acute depressive episode?
There is no clinical evidence specifically addressing sauna during acute MDD episodes in an uncontrolled setting. The Mason trial was conducted with clinical oversight. During an acute episode, heat exposure carries additional risks: dehydration tolerance is reduced, cardiovascular demand is higher, and motivation to maintain the session past the 12–15 minute dynorphin threshold may be significantly impaired. Anyone experiencing a severe depressive episode should prioritise clinical care. Sauna as a maintenance or prevention-focused practice, under non-acute conditions, is where the mechanistic evidence is strongest.
The Bottom Line
The science connecting sauna to mood regulation is more mechanistically grounded than almost any other lifestyle-and-mental-health association in the literature. Ashley Mason's 2024 trial produced a 91.7% remission rate in completers and a 15.83-point BDI-II reduction; the serotonergic pathway from peripheral thermoreceptors to the dorsal raphe nucleus is well characterised; the dynorphin-to-mu-opioid cascade explains both the discomfort during sessions and the extended mood elevation after them. This is not speculation. It is also not yet the standard of care for MDD. Both are true, and the honest position sits between claiming sauna cures depression and dismissing the evidence because the trials are small.
Stay in past the 12-minute mark. The mechanism requires it.
Sources
- Mason A et al. "Whole-body hyperthermia combined with CBT for major depressive disorder" PMC, 2024.
- Hannuksela ML, Ellahham S. "Benefits and risks of sauna bathing" American Journal of Medicine, 2001.
- Laukkanen JA et al. "Cardiovascular and Other Health Benefits of Sauna Bathing: A Review of the Evidence" Mayo Clinic Proceedings, 2018.
- Patrick R & Johnson M. "Sauna use as a lifestyle practice to extend healthspan" Experimental Gerontology, 2021.
Last reviewed: March 2026
Last updated: 2 April 2026
The information in this article is for educational purposes only and is not medical advice. Consult your doctor before beginning any sauna protocol.